Arrowstreet Capital’s Vascular Solutions Inc VASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-84,540
Closed -$4.08M 2935
2016
Q3
$4.08M Buy
84,540
+59,017
+231% +$2.75M 0.01% 707
2016
Q2
$1.06M Buy
25,523
+10,832
+74% +$403K ﹤0.01% 1006
2016
Q1
$478K Sell
14,691
-22,200
-60% -$640K ﹤0.01% 1133
2015
Q4
$1.27M Buy
36,891
+4,400
+14% +$149K 0.01% 924
2015
Q3
$1.05M Buy
+32,491
New +$1.16M 0.01% 910
2015
Q1
Sell
-56,456
Closed -$1.53M 1354
2014
Q4
$1.53M Sell
56,456
-16,677
-23% -$453K 0.01% 789
2014
Q3
$1.81M Hold
73,133
0.01% 619
2014
Q2
$1.62M Buy
73,133
+46,335
+173% +$1.01M 0.01% 635
2014
Q1
$702K Buy
+26,798
New +$667K ﹤0.01% 902

Other funds holding VASC

Arrowstreet Capital's VASC Position: Q4 2016 in Review

Arrowstreet Capital sold out of Vascular Solutions Inc (VASC) in Q4 2016, closing a stake of 84,540 shares — an estimated $4.08M sold.

Arrowstreet Capital first reported a position in VASC in Q1 2014 and held it in 9 quarters. The position peaked at $4.08M in Q3 2016. 163 funds tracked by Wall St. Rank hold VASC as of Q4 2016.

  • Arrowstreet Capital reported no remaining Vascular Solutions Inc position as of Q4 2016 after selling out during the quarter.
  • Arrowstreet Capital sold 84,540 Vascular Solutions Inc shares in Q4 2016, an estimated $4.08M.
  • Arrowstreet Capital first reported a position in Vascular Solutions Inc in Q1 2014 and held it in 9 quarters.
  • Arrowstreet Capital's Vascular Solutions Inc position peaked at $4.08M in Q3 2016.
  • 163 funds tracked by Wall St. Rank held Vascular Solutions Inc as of Q4 2016.

Based on Arrowstreet Capital's 13F filing for Q4 2016, filed 15 Feb 2017.